SOHM Projects Revenue Growth Of 200 Percent In 2011 As Major Launch of Diabetic Products Begins Across India
India Expected To Become The Diabetic Capital of the World By 2015 BUENA PARK, CA, April 6, 2011 – SOHM, Inc. (Pink Sheets: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories … Continue reading
SOHM’s India Based Operations Expand Generic Pharmaceutical Line To Include Life-Style Disease Drugs For Anti-Hypertension, Cardiac Disease, and Cholesterol Reduction
BUENA PARK, CA, February 24, 2011 – SOHM, Inc. (Pink Sheets: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced that SOHM’s India based operations are expanding its generic pharmaceutical line to … Continue reading
SOHM India Forecasts Strong Revenue Growth In Southeast Asia As Its Generic Pharmaceutical Product Line Begins Large Scale Distribution In The Region
Southeast Asia is the Fourth-Largest Pharmaceutical Market in the World, behind the United States, Japan, and Europe. Southeast Asia is also the World’s Fastest-Growing Pharmaceutical Market. BUENA PARK, CA, February 16, 2011 – SOHM, Inc. (Pink Sheets: SHMN), a generic … Continue reading
SOHM Reports Record 2010 Year End With Revenue Growth Increasing 249 Percent
Growth Fueled by Sharp Increase in Demand For SOHM’s Private Label Generic Pharmaceuticals, Strong Uptake of New Products, Expansion of Geographic Target Markets and Addition of Strategic Partners BUENA PARK, CA, February 15, 2011 – SOHM, Inc. (Pink Sheets: SHMN), … Continue reading
SOHM India Announces Purchase Order For Private Label Generic Pharmaceutical Products In Sri Lanka
BUENA PARK, CA, February 15, 2011 – SOHM, Inc. (Pink Sheets: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that SOHM, India has received confirmation of a purchase order to … Continue reading


